Pfizer

The next three months will be crucial for efforts to confront challenges from the Omicron strain of COVID-19, a health expert has said, calling for speeding up the drive to give booster shoots.

Health Minister Fahrettin Koca last week announced the first cases of the Omicron variant in Turkey.

"Because of the new version of Omicron, a third dose of RNA vaccine must be given because it really protects. The first two doses of AstraZeneca protect only 20%.

Three doses of the Pfizer-BioNTech coronavirus vaccine appear effective against the Omicron variant, a lab test indicated - encouraging news, even as Denmark and Britain announced new restrictions to stem surging caseloads.

Σε αρνητικό έδαφος η μετοχή της Pfizer, η οποία τον προηγούμενο μήνα κατέγραφε άνοδο 6,3%

Greece has registered a record number of deaths from COVID-19 on a daily basis, local media reported. 116 deaths were registered in the country yesterday, BTA reported.

The immune response in people who received the first dose of COVID-19 vaccines from Astra Zeneca and Biontech / Pfizer with Moderna was higher, according to a large British study.

Early indications of the severity of the Omicron COVID-19 variant are "a bit encouraging," top U.S. pandemic advisor Anthony Fauci said on Dec. 5, while cautioning more information was still needed.

Turkey aims to vaccinate more than 80 percent of the population against COVID-19, Professor Alper Şen from the Health Ministry's Science Board has said.

The vaccine drive is not moving at the desired speed, but still the vaccination rate in Turkey is higher than many countries in Europe, according to Şen.

Australia on Dec. 5 cleared the first COVID-19 vaccine for children aged five to 11, with the next stage of its vaccine rollout expected to start in early 2022.

Health Minister Greg Hunt said medical regulators had granted provisional approval for the Pfizer-BioNTech vaccine to be administered to younger children for the first time.

The European Medicines Agency said today it had begun reviewing a new vaccine against COVID-19, produced by the French company Valneva - the first step towards approving its use in the European Union, the Associated Press reported.